STOCK TITAN
  1. Home
  2. ARYD

ARYA Sciences Acquisition IV (ARYD) Stock Price, News & Analysis

ARYD NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
11 253 sessions, August 22, 2023 to August 22, 2024
Largest daily move
+36.3% close of August 1, 2024
1-year change
-51.4% closing prices, August 22, 2023 to August 22, 2024

Company Description

ARYA Sciences Acquisition IV (NASDAQ: ARYD) is classified in the blank checks industry and carries a market capitalization of $50.0M.

ARYD has declined 51.4% over the past year. The last closing price was $5.20.

This page collects what Stock Titan holds for ARYD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-51.4%
Performance 1 year
$50.0M
Market Cap
-
Shares outstanding

ARYA Sciences Acquisition IV (ARYD) closed at $5.20 on August 22, 2024. Over the past 12 months, the price has lost 51.4%.

See what a $1,000 investment in ARYD would be worth today

ARYD Metrics & Rankings

Market Cap
$50.0M
View ranking
Month to date
-21.7%
View ranking
YTD
-52.3%
View ranking

Price returns through August 22, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
+3.94%

Adagio Medical Provides Business Updates

+36.30%

Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias

+0.90%

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

acquisition clinical trial
-1.41%

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

acquisition
—

ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering

IPO offering acquisition

ARYA Sciences Acquisition IV has 5 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, clinical trial, IPO, offering. View all ARYD news →

SEC Filings

View All

No SEC filings available for ARYD.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ARYD Company Profile & Sector Positioning

ARYA Sciences Acquisition IV (ARYD) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of ARYA Sciences Acquisition IV (ARYD)?

The current stock price of ARYA Sciences Acquisition IV (ARYD) is $5.2 as of September 4, 2024.

What is the market cap of ARYA Sciences Acquisition IV (ARYD)?

The market cap of ARYA Sciences Acquisition IV (ARYD) is approximately $50.0M. Learn more about what market capitalization means .